BVS vs REG · rev $573.3M vs P/E 34, $12.93B cap
Bioventus Inc (BVS) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
REG does not have a complete income-statement cache yet.
BVS currently screens at market cap $495.1M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the BVS and REG stock pages for the full models.
Not investment advice.